Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charu Gupta

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Kidney International Reports|April 29, 2021
Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research ConsortiumIsa F Ashoor, Robbie A Beyl, Charu Gupta, et al.
BMC Ophthalmology|May 17, 2017
Atypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degenerationHelena Giannakaki-Zimmermann, Giuseppe Querques, Inger Christine Munch, et al.
Applied Clinical Informatics|December 29, 2021
Continuous Remote Patient Monitoring: Evaluation of the Heart Failure Cascade Soft LaunchWei Ning Chi, Courtney Reamer, Robert Gordon, et al.
Scientific Reports|June 5, 2024
Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activityDebasis Sahu, Charu Gupta, Ragothaman M Yennamalli, et al.
The Oncologist|June 9, 2017
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Jean-Frederic Blanc, Steven Miles, et al.
Haematologica|April 4, 2020
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemiaAnuhar Chaturvedi, Charu Gupta, Razif Gabdoulline, et al.
JMIR Research Protocols|August 25, 2022
Continuous Remote Patient Monitoring in Patients With Heart Failure (Cascade Study): Protocol for a Mixed Methods Feasibility StudyCourtney Reamer, Wei Ning Chi, Robert Gordon, et al.
Leukemia|October 6, 2019
In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding siteAnuhar Chaturvedi, Ramya Goparaju, Charu Gupta, et al.
Leukemia|June 25, 2020
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemiaArnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2024
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular CarcinomaBruno Sangro, Peter R Galle, Robin Kate Kelley, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Kidney International Reports|April 29, 2021
Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research ConsortiumIsa F Ashoor, Robbie A Beyl, Charu Gupta, et al.
BMC Ophthalmology|May 17, 2017
Atypical retinal pigment epithelial defects with retained photoreceptor layers: a so far disregarded finding in age related macular degenerationHelena Giannakaki-Zimmermann, Giuseppe Querques, Inger Christine Munch, et al.
Applied Clinical Informatics|December 29, 2021
Continuous Remote Patient Monitoring: Evaluation of the Heart Failure Cascade Soft LaunchWei Ning Chi, Courtney Reamer, Robert Gordon, et al.
Scientific Reports|June 5, 2024
Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activityDebasis Sahu, Charu Gupta, Ragothaman M Yennamalli, et al.
The Oncologist|June 9, 2017
Phase II Study of First-Line Trebananib Plus Sorafenib in Patients with Advanced Hepatocellular CarcinomaGhassan K Abou-Alfa, Jean-Frederic Blanc, Steven Miles, et al.
Haematologica|April 4, 2020
Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemiaAnuhar Chaturvedi, Charu Gupta, Razif Gabdoulline, et al.
JMIR Research Protocols|August 25, 2022
Continuous Remote Patient Monitoring in Patients With Heart Failure (Cascade Study): Protocol for a Mixed Methods Feasibility StudyCourtney Reamer, Wei Ning Chi, Robert Gordon, et al.
Leukemia|October 6, 2019
In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding siteAnuhar Chaturvedi, Ramya Goparaju, Charu Gupta, et al.
Leukemia|June 25, 2020
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemiaArnold Kloos, Konstantinos Mintzas, Lina Winckler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2024
Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular CarcinomaBruno Sangro, Peter R Galle, Robin Kate Kelley, et al.
Pageof 7